Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Ablations of Ghrelin and Ghrelin Receptor Exhibit Differential Metabolic Phenotypes and Thermogenic Capacity during Aging

  • Xiaojun Ma ,

    Contributed equally to this work with: Xiaojun Ma, Ligen Lin

    Affiliations Division of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America

    ⨯
  • Ligen Lin ,

    Contributed equally to this work with: Xiaojun Ma, Ligen Lin

    Affiliation USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America

    ⨯
  • Guijun Qin,

    Affiliation Division of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    ⨯
  • Xinping Lu,

    Affiliation Digestive Disease Branch, National Institutes of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    ⨯
  • Marta Fiorotto,

    Affiliation USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America

    ⨯
  • Vishwa D. Dixit,

    Affiliation Laboratory of Neuroendocrine-Immunology, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States of America

    ⨯
  • Yuxiang Sun

    yuxiangs@bcm.edu

    Affiliations USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America, Huffington Center on Aging, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America

    ⨯

Abstract

Background

Obesity is a hallmark of aging in many Western societies, and is a precursor to numerous serious age-related diseases. Ghrelin (Ghrl), via its receptor (growth hormone secretagogue receptor, GHS-R), is shown to stimulate GH secretion and appetite. Surprisingly, our previous studies showed that Ghrl-/- mice have impaired thermoregulatory responses to cold and fasting stresses, while Ghsr-/- mice are adaptive.

Methodology/Principal Findings

To elucidate the mechanism, we analyzed the complete metabolic profiles of younger (3–4 months) and older (10–12 months) Ghrl-/- and Ghsr-/- mice. Food intake and locomotor activity were comparable for both null mice and their wild-type (WT) counterparts, regardless of age. There was also no difference in body composition between younger null mice and their WT counterparts. As the WT mice aged, as expected, the fat/lean ratio increased and energy expenditure (EE) decreased. Remarkably, however, older Ghsr-/- mice exhibited reduced fat/lean ratio and increased EE when compared to older WT mice, thus retaining a youthful lean and high EE phenotype; in comparison, there was no significant difference with EE in Ghrl-/- mice. In line with the EE data, the thermogenic regulator, uncoupling protein 1 (UCP1), was significantly up-regulated in brown adipose tissue (BAT) of Ghsr-/- mice, but not in Ghrl-/- mice.

Conclusions

Our data therefore suggest that GHS-R ablation activates adaptive thermogenic function(s) in BAT and increases EE, thereby enabling the retention of a lean phenotype. This is the first direct evidence that the ghrelin signaling pathway regulates fat-burning BAT to affect energy balance during aging. This regulation is likely mediated through an as-yet-unidentified new ligand of GHS-R.

Citation: Ma X, Lin L, Qin G, Lu X, Fiorotto M, Dixit VD, et al. (2011) Ablations of Ghrelin and Ghrelin Receptor Exhibit Differential Metabolic Phenotypes and Thermogenic Capacity during Aging. PLoS ONE 6(1): e16391. https://doi.org/10.1371/journal.pone.0016391

Editor: Krisztian Stadler, Pennington Biomedical Research Center, United States of America

Received: October 21, 2010; Accepted: December 14, 2010; Published: January 26, 2011

Copyright: © 2011 Ma et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: The authors are very grateful to the agencies which supported this work: USDA/ARS CRIS fund ARS 6250-51000-055 (YS), NIH/NIA grant 1R03AG029641-01 (YS) and the NIH-Diabetes and Endocrinology Research Center (P30DK079638) at Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Energy homeostasis is determined by the balance between energy intake and energy expenditure; even small differences over prolonged time periods in the balance between energy intake and energy expenditure can result in the development of obesity, insulin resistance and other serious metabolic disorders. Ghrelin is an acylated 28-amino-acid peptide predominantly produced by the X/A-like enteroendocrine cells in the stomach [1], and is the only known circulating orexigenic hormone. Ghrelin increases growth hormone (GH) release, stimulates appetite, and induces fat deposition [2], [3], [4]. Many studies have suggested that ghrelin plays a role in long-term body weight regulation, and changes in circulating ghrelin levels reflect an individual's nutritional status [5], [6], [7]. Ghrelin plays a key role in the regulation of metabolism and energy homeostasis. The biologically relevant receptor of ghrelin is a G-protein-coupled receptor named Growth Hormone Secretagogue Receptor (GHS-R) [8]. By activating GHS-R in the hypothalamus, ghrelin stimulates orexigenic neurons and promotes preferential ingestion of fat [9], [10], [11]. Using GHS-R null mice, we unambiguously demonstrated that GHS-R mediates ghrelin's stimulatory effects on GH-release and appetite [12]. In the last few years, we and others have shown that ghrelin has effects in tissues that do not express GHS-R; thus there are likely other ghrelin subtype receptor(s) apart from GHS-R [13], [14], [15], [16], [17]. We recently reported that Ghrl-/- mice have impaired abilities to manifest and integrate sleep and thermoregulatory responses under metabolic challenges induced by cold temperature and fasting; intriguingly, Ghsr-/- mice exhibit the normal responses of their WT counterparts [18]. These observations suggest that, although GHS-R is a biologically relevant ghrelin receptor that regulates GH and food intake, ghrelin and GHS-R also may have independent noncanonical functions, so that the phenotypes of Ghrl-/- and Ghsr-/- mice are different.

There are two types of adipose tissues: energy-storing white adipose tissue (WAT) and energy-burning brown adipose tissue (BAT). BAT is primarily responsible for non-shivering thermogenesis in rodents and human neonates; it has emerged recently that variations in BAT activity contribute to differences in energy expenditure even among adult humans [19]. Thermogenesis in BAT is achieved by adrenergic-stimulation of both activation and expression of uncoupling protein 1 (UCP1) in the mitochondria. UCP1, located in the inner mitochondrial membrane, recruits free fatty acid (FFA) into the mitochondria to generate heat [20], [21]. BAT activity is positively correlated with energy expenditure and negatively correlated with body fat content [19], [22]. BAT is responsible for more than half of the body's total oxygen consumption in small animals; these animals contain proportionately greater amounts of BAT when compared to larger mammals, including humans. Increased body temperature of about 1°C could thermodynamically correspond to a 10% increase of metabolic rate [23]. Dysregulation of adaptive thermogenesis in BAT has been shown to impact body fat content, and promote obesity and diabetes [20], [24], [25].

Aging is associated with a loss of lean mass, and is often accompanied by an increase of body fat mass which reflects a positive energy balance leading to weight gain [26]. Furthermore, aging is associated with diminished thermogenic function; aging humans have significantly reduced BAT mass and BAT activity [22], [24], [27], [28], [29], [30]. This blunted thermogenic response also contributes to age-associated obesity and energy imbalance. UCP1 is the key regulator of thermogenesis in BAT. However, genes which activate UCP1 in BAT are not well characterized, and there is hardly any information on the genes that age-dependently regulate thermogenesis.

To further our understanding of the roles of ghrelin and GHS-R in fat metabolism and energy homeostasis, we have analyzed the metabolic profiles and BAT thermogenic capacity of our congenic Ghrl-/- and Ghsr-/- mice in detail at both younger and older ages. Our results showed that older Ghsr-/- mice maintain a youthfully lean phenotype, with a decreased percentage of body fat and increased lean mass; whereas Ghrl-/- mice do not. Furthermore, this lean phenotype of older Ghsr-/- mice is independent of difference in food intake or physical activity, but is due to higher energy expenditure. Our data further demonstrated that mitochondrial content and thermogenic regulator UCP1 were elevated in the BAT of the older Ghsr-/- mice, suggesting increased thermogenesis. To our knowledge, this is the first study which shows that GHS-R has a role in thermogenic regulation of energy-burning BAT in mice. Ghsr ablation enhanced thermogenic capacity in older mice, but not younger mice, suggesting GHS-R plays a pivotal role in the aging-related dysfunction of BAT. The differential metabolic phenotypes revealed by ghrelin- null mice and Ghsr- null mice show the complexity of ghrelin signaling pathway, and suggest the possible existence of additional unidentified GHS-R ligand(s).

Results

Reduced body weights and body fat in older Ghsr-/- mice, but not in older Ghrl-/- mice

To characterize the effects on growth and metabolism of deficiency in ghrelin- and ghrelin-receptor (GHS-R), we compared body weights and body compositions of WT, Ghrl-/- and Ghsr-/- mice at ages of 3–4 (younger) and 10–12 (older) months. As illustrated in Fig. 1A and 1B, there was no significant difference in body weights between younger null and WT mice, regardless of genotype. We used quantitative nuclear magnetic resonance (NMR) to determine the body composition of the mice. There were no differences among genotypes in body composition at younger age (Fig. 1C and 1D). There were also no significant differences in body composition between older Ghrl-/- mice and their WT controls (Fig. 1C). In contrast, older Ghsr-/- mice showed a statistically significant reduction in body weight and fat mass compared with WT controls, while the proportion of lean mass was significantly higher than that of WT mice (Fig. 1B and 1D). Ghrelin is believed to play important regulatory roles in appetite and satiety, and it is logical to assume that ghrelin and Ghsr ablation will lead to decreased food intake. However, regardless of age there was no difference in the average daily food intake among WT, Ghrl-/- and Ghsr-/- mice (Fig. 1E and 1F). These data suggest that the lean phenotype of older Ghsr-/- mice is not likely due to reduced energy intake (food ingestion).

thumbnail
Download:
Figure 1. Body weight, body composition and daily food intake of WT, Ghrl-/-, and Ghsr-/- mice.

The data of Ghrelin-null mice are on the left (A, C, E), and the data for GHS-R-null mice are on the right (B, D, F). (A and B): Both younger and older Ghrl-/- mice had similar body weight compared to WT mice, while older Ghsr-/- mice had significantly lower body weight than WT mice. (C and D): The body composition of Ghrl-/- mice did not differ from age-matched WT mice, while older Ghsr-/- mice showed decreased proportions of body fat and increased proportions of lean mass. (E and F): The daily food intake of both null mice was comparable to that of their WT controls. The values are presented as mean ± SEM (n = 6–8 per group); *, P<0.05, null vs. WT mice.

https://doi.org/10.1371/journal.pone.0016391.g001

Ablation of GHS-R leads to marked increases in energy expenditure and resting metabolic rate in older Ghsr-/- mice

Changes in body fat mass occur when there is an imbalance between energy intake and energy expenditure. Because food intake was comparable for both Ghrl-/- and Ghsr-/- mice compared to their WT counterparts, a potential explanation for the lean phenotype of older Ghsr-/- mice might be an increase in metabolic rate. We examined the metabolic profiles of younger and older Ghrl-/- and Ghsr-/- mice by using an Oxymax/CLAMS system (Columbus Instruments, Columbus, OH). To minimize the confounding effects of stress, mice were caged individually for 1 week and then placed in metabolic cages for at least 4 days before the indirect calorimetry testing. After 24 h of acclimatization in the calorimetry chamber, 48 h of indirect calorimetry data were collected. Both younger Ghrl-/- and Ghsr-/- mice had similar energy expenditure levels compared to their WT counterparts (representative 24-hr profiles shown in Fig. 2A and 2C). Older mice in both genotypes showed reduced energy expenditure when compared to younger mice. The energy expenditure of older Ghsr-/- mice was significantly higher than those of WT mice, and the difference persisted throughout the light and dark phases (Fig. 2D); meanwhile, older Ghrl-/- mice failed to show a difference (Fig. 2B). We also calculated energy expenditure according to adjusted metabolic body mass (kg0.75), which represents the metabolic rate of an animal independent of the size of the body [31], [32]. The adjusted energy expenditure in older Ghsr-/- mice remained marked higher than that of WT mice (data not shown). Additionally, we determined the respiratory exchange ratio (RER) by indirect calorimetry. There were no differences in RER (Fig. S1), regardless of age and genotypes; this suggests that neither ghrelin-ablation nor GHS-R ablation affects fuel substrate preference under regular chow feeding.

thumbnail
Download:
Figure 2. Representative energy expenditure (EE) profiles of WT, Ghrl-/- and Ghsr-/- mice.

The data for Ghrelin-null mice are on the top (A, B), and the data for GHS-R null mice are on the bottom (C, D). (A and B): The energy expenditure of neither younger nor older Ghrl-/- mice differed from their WT control mice. (C and D): Older Ghsr-/- mice had a higher energy expenditure when compared with WT mice, whereas there was no difference in younger mice. The values are presented as mean ± SEM (n = 6–8 per group). *, P<0.05, null vs. WT mice.

https://doi.org/10.1371/journal.pone.0016391.g002

Resting metabolic rate (RMR) is responsible for burning up to 60–70% of total expended calories [33]. We determined the RMR in these mice to further elucidate whether the differences in total energy expenditure were primarily due to differences in RMR. We found that RMR was comparable between Ghrl-/- and WT mice, regardless of age (Fig. 3A), but was significantly higher in older Ghsr-/- mice compared with their WT counterparts (Fig. 3B). These data collectively suggest that the lean phenotype of old Ghsr-/- mice is primarily contributed by the elevated metabolic rate.

thumbnail
Download:
Figure 3. Resting metabolic rate (RMR) and locomotor activity of WT, Ghrl-/-, and Ghsr-/- mice.

(A): The RMR was not affected in either younger or older Ghrl-/- mice when compared with WT mice. (B): Older Ghsr-/- mice had a higher RMR compared with WT mice, whereas younger mice show similar RMR. (C and D): Activity decreases with aging in both mouse models. No significant differences in activity between Ghrl-/- (C) or Ghsr-/- (D) mice compared with their WT control mice. The values are presented as mean ± SEM (n = 6–8 per group); *, P<0.05 null vs. WT mice.

https://doi.org/10.1371/journal.pone.0016391.g003

To further determine whether differences in physical activity contributed to the higher energy expenditure/metabolic rate of older Ghsr-/- mice, we monitored spontaneous locomotor activity of these mice while in the calorimetry chambers. Neither the total daily locomotor activity (Fig. 3C and 3D) nor the locomotor activity during light and dark periods (data not shown) was altered for Ghrl-/- or Ghsr-/- mice when compared to their WT controls, regardless of age. Again, the data show that increased energy expenditure of older Ghsr-/- mice was not due to elevated activity in these null mice.

Increased mitochondrial content and UCP1 expression in BAT of older Ghsr-/- mice

WAT is composed of large adipocytes that store energy in the form of triglycerides; in contrast, BAT consists of small adipocytes that contain a reduced amount of triglyceride stored in the form of multilobular lipid droplets [20]. The BAT adipocytes have a high mitochondrial density and express the BAT-specific regulator UCP1. Mitochondrial UCP1 is the hallmark regulator of mitochondrial biogenesis and thermogenesis; when activated, UCP1 dissipates the transmembrane proton gradient and generates heat [34]. The H&E staining of BAT sections of older Ghsr-/- mice showed higher percentages of multilobular adipocytes and increased cellularity (dark blue nuclei) as shown in Fig. 4. To investigate the mechanism of the increased energy expenditure observed in the older Ghsr-/- mice, we further studied the mRNA expression of UCP1 in BAT of older Ghsr-/- and Ghrl-/- mice by quantitative RT-PCR. Consistent with our calorimetry data, no difference was observed in BAT of older Ghrl-/- mice when compared to that of WT mice (Fig. 5A). Remarkably, however, older Ghsr-/- mice exhibited significantly increased UCP1 mRNA expression when compared with their WT counterparts (Fig. 5B). Consistently, Western blots showed that UCP1 protein level was increased in older Ghsr-/- mice (Fig. 5C), further supporting the conclusion of elevated thermogenic function in BAT. We also demonstrated that mitochondrial DNA content was significantly increased in older Ghsr-/- mice as compared to that of WT mice, indicative of increased mitochondrial content and in line with the enhanced mitochondrial function in the BAT of older Ghsr-/- mice. These data suggest that GHS-R has a novel role in thermogenesis in BAT, and that GHS-R suppression enhances heat production in BAT. This may in turn lead to increased fat mobilization and results in the lean phenotype observed in older Ghsr-/- mice.

thumbnail
Download:
Figure 4. Morphology of interscapular brown adipose tissue (BAT) of older WT, Ghrl-/-, and Ghsr-/- mice.

(A): The morphology was very similar between older Ghrl-/- and their WT counterparts. (B): BAT of older Ghsr-/- mice showed higher percentages of multilobular adipocytes and increased cellularity (dark blue nuclei). These are representative H & E staining of BAT paraffin sections from 4–8 mice.

https://doi.org/10.1371/journal.pone.0016391.g004

thumbnail
Download:
Figure 5. UCP1 expression and mitochondrial DNA content in BAT of older mice.

Relative quantitative RT-PCR was used for mRNA analysis, and the expression of average value of WT was defined as 1. (A): UCP1 mRNA expression was not affected in Ghrl-/- mice. (B): UCP1 mRNA level was increased in BAT of Ghsr-/-mice compared with WT counterparts. (C): UCP1 protein was increased in the BAT of older Ghsr-/- mice. Sample Western blots on top and quantization at the bottom. (D) Ghsr-/- mice had increased mitochondrial DNA content in BAT compared with that of WT mice. The values are presented as mean ± SEM (n = 9–12 per group); *, P<0.05 null vs. WT mice.

https://doi.org/10.1371/journal.pone.0016391.g005

GHS-R ablation improves lipid profiles

Obesity is often correlated with dysregulations of lipid metabolism, which ultimately leads to insulin resistance, type 2 diabetes and cardiovascular diseases. The lipid levels were similar between older Ghrl-/- and WT mice (Fig. 6A). By contrast, in older Ghsr-/- mice, total cholesterol and triglycerides levels were statistically lower compared with WT mice (Fig. 6B). The data show that ablation of GHS-R improves lipid metabolism. This suggests that old Ghsr-/- mice may have healthier outcomes.

thumbnail
Download:
Figure 6. Fasting lipid profile in older WT, Ghrl-/- and Ghsr-/- mice.

(A): Lipid levels were not different between WT and Ghrl-/- mice. (B): Levels of total cholesterol (CHOL) and triglycerides (TG) were significantly decreased in Ghsr-/- mice compared with WT counterparts. The values are presented as mean ± SEM (n = 9–12 per group); *, P<0.05 null vs. WT mice.

https://doi.org/10.1371/journal.pone.0016391.g006

Discussion

Pharmacological administration of exogenous ghrelin generates robust orexigenic effects [4], [35], [36]. However, paradoxically, ghrelin levels are lower in obese subjects but higher in lean subjects [37], [38]. The role of endogenous ghrelin in energy homeostasis remains puzzling. We and others have reported that when fed a regular chow diet, younger Ghrl-/- and Ghsr-/- mice have normal growth rates, food intake, and body composition, which are not different from WT controls [39], [40], [41], [42]. When the mice are fed a high fat diet right after weaning, Ghrl-/- and Ghsr-/- mice appear to prevent diet-induced obesity [41], [42]. Interesting, this protective effect disappears when the high fat diet is fed starting at an adult age [39]. Animals gain weight as they age due to increased fat deposition and reduced energy expenditure [26], [43], [44], [45]. As shown in Fig. 1 of our study, the body weights and proportions of fat mass of the mice increased as the mice aged. Consistent with our previous reports, our present study found no significant difference in body weights among younger (3–4 months old) WT, Ghrl-/-, and Ghsr-/- mice. By 10–12 months of age, however, body weights of Ghsr-/- mice were significantly lower than those of WT mice, whereas body weights of Ghrl-/- mice were still comparable with same-aged WT mice (Fig. 1A and 1B). During aging, percentage of body fat increases and lean mass decreases. Using NMR, we examined the impact of ghrelin-signaling on body composition during aging. Remarkably, older Ghsr-/- mice had about 44% less body fat than their WT counterparts, while the difference in older Ghrl-/- mice was much less pronounced (Fig. 1C and 1D). Our data suggest that GHS-R ablation, but not ghrelin ablation, maintains a youthfully lean phenotype concurrent with aging.

A number of studies have shown that acute administration of ghrelin stimulates food intake, and there are ample results to demonstrate that chronic ghrelin administration resulted in increased fat deposition [4], [36], [46]. However, similar to our previous reports on younger mice [12], [40], daily food intake in older Ghrl-/- or Ghsr-/- mice also made no impact on fat deposition (Fig. 1E and 1F). It is clear that the reduction in body weights and changes in body fat/lean ratio in older Ghsr-/- mice are independent of energy intake (food ingestion).

Imbalance between energy intake (food ingestion) and energy expenditure (activity and/or heat production) leads to changes in body composition [47]. A positive energy balance leads to weight gain, a negative balance results in weight loss, and the weight being primarily composed of fat. It has been shown that ghrelin is involved in the regulation of energy expenditure; further, an inverse relationship exists between ghrelin and energy expenditure in normal-weight humans [48], [49]. Ghrelin induces positive energy balance by stimulating feeding behavior and suppressing sympathetic nerve activity in BAT [50], [51]. Higher levels of ghrelin are associated with lower levels of resting thermogenesis and postprandial thermogenesis in humans [52]. However, it is unknown whether ghrelin's effect on BAT is mediated through GHS-R, and whether Ghrl-/- or Ghsr-/- mice have similar BAT phenotypes. As expected, we showed that energy expenditure decreases as the mice age (Fig. 2). Because there was no difference in food intake (Fig 1E and 1F), we speculate that the increased energy expenditure may explain the lean phenotype of older Ghsr-/- mice. Indeed, older Ghsr-/- mice exhibited a pronounced elevation in energy expenditure, and also maintained an impressively youthful higher energy expenditure profile when compared with age-matched WT mice (Fig 2D). Because there was no difference in activity level (Fig. 3D), this indicates that in older Ghsr-/- mice, the increased energy expenditure was primarily due to increased heat production in BAT. In humans, RMR is lower in older individuals than in younger individuals, and that is entirely determined by body composition [53]. Similarly, we detected decreased RMR in older WT mice, while older Ghsr-/- mice have a significantly higher RMR than that of older WT mice, and to maintain an elevated youthful RMR (Fig. 3B). These data further support the conclusion that the cause of the lean phenotype in older Ghsr-/- mice is due to increased metabolic rate but not due to changes with appetite or activity.

It has been reported that Ghrl-/- and Ghsr-/- mice have decreased RER values with diet-induced obesity, and indicate that the mice preferentially metabolize fat as an energy source [41], [42]. However, our high fat diet study with our congenic mice did not show a difference in RER [39]. In our present study of age-induced obesity, we also did not detect a reduction of RER (Fig. S1). We conclude that ghrelin and GHS-R are not determining factors for fuel preference when regular chow is fed.

BAT plays an important role in energy metabolism, and thermogenic activation of BAT can directly affect metabolic rate. Activation of BAT function is correlated with increased mitochondrial content and activity [54]. We observed that there is no difference in morphology between younger and older Ghrl-/- mice, whereas the BAT of older Ghsr-/- mice has an increased abundance of multilobular adipocytes (Fig. 4) and higher mitochondrial DNA content in the BAT of old Ghsr-/- mice (Fig. 5D). Also, we detected increased cellularity (dark blue nuclei), which suggests that deletion of GHS-R promotes adipogenesis in BAT (Fig. 4). These are all in support of enriched mitochondrial content.

UCP1 is a key regulator of thermogenesis, which allows protons to enter the mitochondrial matrix and dissipates energy as heat in preference to the energy being used for ATP production [20], [21]. Consistent with this histological evidence, we have shown increased UCP1 mRNA and protein expression in the BAT of older Ghsr-/- mice (Fig. 5B and 5C), but not in older Ghrl-/- mice. Thus, our data show that Ghsr-/- mice, but not Ghrl-/- mice, have enhanced mitochondrial activity. Our data collectively showed increased mitochondrial content and enhanced mitochondrial activity in the BAT of older Ghsr-/- mice; this may in turn elevate thermogenesis and attenuate the age-associated decline of thermogenic function.

We previously showed that GHS-R expression was not detected in brown adipose tissues of younger mice [55]. Interestingly, our new data show lower level of GHS-R is expressed in BAT of older mice (unpublished data). We have seen increased circulating ghrelin levels during aging [55], which suggest age-related “ghrelin resistance” in older animals. The differential expression patterns in younger versus older mice suggest that GHS-R may be “turned on” specifically in BAT during aging, and may directly regulate the function of BAT. Animal models of fat depot-specific deletion of GHS-R, and/or GHS-R inducible systems turned on during aging, may provide further direct evidence as to whether GHS-R is a key regulator in fat metabolism during aging.

In rodents, it has been shown that BAT may have protective effects during aging. Calorie restriction (CR) is known to have beneficial effects on health and longevity. It has been shown that CR prevents the age-related declines in mitochondrial mass, cyclooxygenase activity and uncoupling levels in BAT of rats [56]. Our data showed that ablation of GHS-R increases thermogenic capacity in BAT, as well as energy expenditure; the increased energy demand created by this enhanced metabolic activity in BAT would support increased fat mobilization, and result in the reduction of body weight. Obesity has many significant deleterious consequences, including lipid dysregulation. We detected an improved lipid profile in older Ghsr-/- mice (Fig. 6), which further supports the conclusion that older Ghsr-/- mice have a healthier lean phenotype during aging which placed them at lower risk for diabetes and cardiovascular disease. It is possible that GHS-R is involved in mediating a CR-induced beneficial metabolic state via BAT thermogenesis. Moreover, the inhibition of GHS-R may unravel the beneficial effects of CR on longevity without dieting or excise. To our knowledge, this is the first study using null mice to demonstrate that GHS-R regulates thermogenesis in BAT, thus providing the first evidence that GHS-R regulates BAT thermogenesis, suggesting that GHS-R antagonism may have protective effects against age-induced obesity.

The phenotype we observed in Ghsr-/- mice could result from GHS-R-mediated effects in central, peripheral and/or hormonal levels. Thyroid hormones are important regulators of RMR and thermogenesis [57], [58]. However, serum T3 and T4 levels were comparable in WT and Ghsr-/- mice (unpublished data), suggesting that the elevated RMR of older GHS-R null mice is not due to changes in circulating thyroid hormones; nevertheless, we cannot preclude the possibility of enhanced thyroid hormone activity in Ghsr-/- mice locally, at the hypothalamic level [59]. GH is another known regulator that plays important roles in adiposity. There is a strong inverse association between visceral fat accumulation and blunted GH secretion in adults [60], [61]. GH is the primary regulator of IGF-1. We previously showed that GHS-R mediates the GH stimulatory effects of ghrelin, so it was expected when older Ghsr-/- mice showed reduced IGF-1 (Fig. S2). It was surprising, however, that IGF-1 levels in older Ghrl-/- mice were unchanged when compared to that of WT mice. The reduced IGF-1 level suggests that GH is likely decreased in the older Ghsr-/- mice, but it cannot explain the lean phenotype. We thus conclude that neither thyroid hormone nor the GH signaling pathway is likely to be mediating the adipose phenotype.

It is intriguing that we have observed differential thermogenic phenotypes in older Ghsr-/- and Ghrl-/- mice. Even though GHS-R is considered a physiologically relevant receptor for ghrelin, our current data of differential metabolic phenotypes of older Ghrl-/- and Ghsr-/- mice challenges current dogma. Our study adds to the increasing body of literature that there is another as-yet-unidentified GHS-R ligand(s) besides ghrelin that regulate thermogenic function in BAT. Three peptides are derived from the preproghrelin gene: ghrelin (acylated ghrelin), des-acyl ghrelin and obestatin [62]. Acylated ghrelin, which contains an n-octanoic acid at the third Ser residue, activates GHS-R. In contrast, des-acyl ghrelin and obestatin do not activate this receptor. Since des-acyl ghrelin does not activate GHS-R, it initially was thought to be biologically inactive. Subsequent studies demonstrated that in addition to acylated ghrelin, des-acyl ghrelin also stimulates lipid accumulation in human visceral adipocytes [63]. Furthermore, both acylated ghrelin and des-acyl ghrelin have adipogenic effects in bone marrow, while a synthetic GHS-R agonist does not; this suggests that acylated ghrelin and/or des-acyl ghrelin activate receptors other than GHS-R [64]. We have shown that des-acyl ghrelin has ghrelin-like effects on feeding which are independent of the activation of GHS-R, and is mediated through orexin [15]. In contrast to ghrelin, obestatin suppresses appetite and enhances energy expenditure [62] and has a leptin-like role in the regulation of metabolism [65], [66], [67]. It was reported that chronic treatment of ghrelin decreases UCP1 expression in BAT [68]; but it is unknown whether the effect is mediated through GHS-R. We recently reported that Ghrl-/- mice, but not Ghsr-/- mice, are hypothermic under cold and fasting stress; intriguingly, obestatin attenuates the hypothermic response of Ghrl-/- mice [18]. Our Ghrl-/- mice have neither ghrelin nor obestatin. On the other hand, Ghsr-/- mice have ghrelin and obestatin, but only ghrelin signaling is blocked in these mice. Our ghrelin-null has a BAT phenotype different from that of Ghsr-null mice, which invites the questions: Whether ghrelin and obestatin have opposite thermogenic effects on BAT? Whether the BAT phenotype of Ghsr-/- mice can be explained by unopposed effect of obestatin? These observations highlight the complexity of the ghrelin signaling pathway, further investigation is needed.

In conclusion, our study demonstrates differential effects for deficiency of ghrelin- and GHS-R on body composition and energy homeostasis during aging. The decrease of body fat and increase of lean mass in older Ghsr-/- mice are independent of food intake or activity; they are due to increased energy expenditure might be resulted from enhanced thermogenic capacity in BAT. Our data demonstrate for the first time that GHS-R regulates fat-burning BAT to regulate adiposity and metabolism without affecting energy intake or activity. Thus, GHS-R plays an important role in energy homeostasis during aging, and GHS-R antagonists may be a paradigm-shifting new class of drugs that can prevent age-associated obesity.

Materials and Methods

Animals

All procedures used in animal experiments were approved by the Institution of Animal Care and Use Committee at Baylor College of Medicine. The generation of Ghrl-/- and Ghsr-/- mice has been previously described [12], [40]. All mice were on a pure C57BL/6J background, and have been backcrossed to C57BL/6J for 13 generations. Mice were maintained under conditions of controlled temperature (∼75°F) and illumination (12-hour light/12-hour dark cycle, 6am to 6pm) with free access to water and regular mouse chow (TD. 2920X, 16% of calories from fat, 60% from carbohydrates, 24% from protein, Harlan Teklad, Madison, WI). Age-matched male Ghrl-/-, Ghsr-/- and their WT controls were used in the studies; mice were 3-4 months old (younger group) and 10–12 months old (older group). The amount of food consumed was monitored daily for 1–2 weeks in a Comprehensive Laboratory Animal Monitoring System (Columbus Instruments, Columbus, OH). All procedures used in animal experiments were approved by the Institution of Animal Care and Use Committee at Baylor College of Medicine.

Body composition and indirect calorimetry

Whole-body composition (fat and lean mass) of Ghrl-/-, Ghsr-/- and WT mice was measured by an Echo MRI-100 whole-body composition analyzer (Echo Medical Systems, Houston, TX). Metabolic parameters were obtained by using an Oxymax (Columbus Instruments, Columbus, OH) open-circuit indirect calorimetry system for 72 h. The first 24 h was considered the acclimation phase, and data were analyzed only for the final 48 h. Mice were individually caged in chambers and given free access to regular chow and water for 1-week prior to the tests. Oxygen consumption (VO2) (ml/h), carbon dioxide production (VCO2) (ml/h), and locomotor activity (beam break counts) were measured. Respiratory exchange ratio (RER) and energy expenditure (EE, or heat generation) were calculated from VO2 and VCO2 gas exchange data as follows: RER =  VCO2/VO2 and EE =  (3.815+1.232×RER) × VO2 [69]. Energy expenditure was then normalized to body weight. Locomotor activity was measured on x- and z-axes using infrared beams to count the number of beam breaks during the recording period. Resting metabolic rate (RMR) for each mouse was determined by averaging of lowest plateau region of energy expenditure curve corresponding to resting periods, as previously described [70].

Histological analysis

BAT was fixed overnight in 10% formalin at room temperature, dehydrated and embedded in paraffin. Then tissue blocks were sectioned at 5 µm for H&E staining. The H&E staining was carried out following the standard protocols [71].

Analysis of gene expression

BAT was snap-frozen in liquid nitrogen and stored at −80°C. Total RNA was extracted from frozen tissue samples using TRIzol Reagent (Invitrogen, Carlsbad, CA). RNA was subsequently treated with DNase (Ambion, Austin, TX) and its integrity was assessed by performing 1.5% agarose gel electrophoresis in the presence of formaldehyde; its concentration was determined by NanoDrop. RNA was reverse-transcribed using Superscript III First Strand Synthesis System (Invitrogen, Carlsbad, CA). Quantitative RT-PCR was performed in triplicate, as previously described [72]. Mouse UCP1 gene-specific primers were obtained from Applied Biosystems (Mm00494070_m1). 18S and β-actin were used as the housekeeping controls. Relative levels of UCP1 mRNA expression were shown as fold expression between null vs. WT mice.

Western blot analysis

Tissues were lysed in RIPA buffer with complete protease inhibitor cocktail (Roche Inc.). Protein concentration was determined with BCA protein assay kit (Pierce, Rockford, IL). Twenty microgram protein of each sample was separated by SDS-PAGE and electro-transferred to nitrocellulose membrane for immunoblot analyses. The following antibodies were used: anti-UCP1 (Millipore, 1∶1,000), anti-β-actin (Santa Cruz Biotechnology, 1∶1,000), HRP-conjugated anti-mouse (GE Healthcare UK Limited, 1∶10,000), anti-rabbit (GE Healthcare UK Limited, 1∶10,000). The SuperSignal West Pico Chemiluminescent kit (Pierce) was used for the Westerns.

Extraction and quantification of mitochondrial DNA

Mitochondrial DNA (mtDNA) was extracted and quantified as described with modification [73]. Briefly, interscapular BAT was dissected and homogenized in isolation buffer (300 mM sucrose, 1 mM EDTA, 5 mM MOPS, 5 mM KH2PO4, 0.01% BSA, pH 7.4) with a glass homogenizer. The homogenate was first filtered through a layer of gauze. Nuclear and cell debris fraction was isolated by centrifugation at 800 g for 10 min at 4°C. The resulting supernatant was subjected to centrifugation at 8,000 g for 10 min at 4°C. Aliquots of the nuclear and mitochondrial fractions were digested overnight in lysis buffer (10 mM Tris, pH 8.0, 10 mM EDTA, 10 mM NaCl, 0.5% SDS, 100 µg/ml Proteinase K) at 37°C. Nuclear and mitochondrial DNA was extracted using the phenol/chloroform method. Nuclear DNA was quantified by NanoDrop (ND-1000 Thermo Scientific). Mitochondrial DNA was linearized by digestion with Bcl-I for 3 h at 50°C, and then boiled for 5 min. Samples were centrifuged at 7,000 g for 5 min, and the resulting supernatant was used for subsequent PCR amplification. PCR was performed to amplify a 162-nt region of the mitochondrial NADH dehydrogenase. The primer sequences were 5′-TACACGATGAGGCAACCAAA-3′ and 5′-GGTAGGGGGTGTGTGTTGTGAG-3′. The amplified PCR product of mtDNA and total DNA were quantified by spectrometry (NanoDrop), and the ratio of mtDNA/total DNA was calculated.

Plasma analysis

Plasma samples were obtained by low-speed centrifugation of blood samples from 24 h-fasted mice. The assay kits were supplied by Roche Diagnostics Corporation, (Indianapolis, IN). Cholesterol and triglyceride were determined by enzymatic colorimetric methods; LDL, HDL, and VLDL were determined by homogeneous enzymatic colorimetric methods.

Supporting Information

Figure S1.

Respiratory exchange ratio (RER) of younger and older WT, Ghrl-/-, and Ghsr-/- mice. (A and B): The RER of Ghrl-/- mice did not differ from WT mice in either younger or older groups. (C and D): Both younger and older Ghsr-/- mice show similar RER compared with WT mice. The values are presented as mean ± SEM (n = 6–8 per group).

https://doi.org/10.1371/journal.pone.0016391.s001

(TIF)

Figure S2.

Plasma IGF-1 levels in older WT, Ghrl-/- and Ghsr-/- mice. Plasma IGF-1 levels were similar in WT and Ghrl-/- mice (A), whereas older Ghsr-/- mice showed significantly decreased IGF-1 levels when compared with their WT controls (B). The values are presented as mean ± SEM (n = 7–13 per group); *, P<0.05 null vs. WT mice.

https://doi.org/10.1371/journal.pone.0016391.s002

(TIF)

Acknowledgments

We thank Dr. Nancy F. Butte and Mr. Firoz A. Vohra at Children's Nutrition Research Center and Department of Pediatrics at Baylor College of Medicine for their insightful advice and input in calorimetry studies. We also thank Iyabo E. Henshaw for her technical assistance in qPCR analysis. We also thank Dr. Miao-Hsueh Chen at Children's Nutrition Research Center at Baylor College of Medicine for her insightful critique of the manuscript and Mr. Michael R. Honig for his excellent editorial assistance.

Author Contributions

Conceived and designed the experiments: YS VDD. Performed the experiments: XM LL. Analyzed the data: XM LL MF. Contributed reagents/materials/analysis tools: GQ XL. Wrote the paper: XM LL MF YS.

References

  1. 1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656–660.
  2. 2. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, et al. (2001) A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86: 4552.
  3. 3. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, et al. (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86: 5992.
  4. 4. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, et al. (2001) A role for ghrelin in the central regulation of feeding. Nature 409: 194–198.
  5. 5. Holdstock C, Engstrom BE, Ohrvall M, Lind L, Sundbom M, et al. (2003) Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 88: 3177–3183.
  6. 6. Palik E, Baranyi E, Melczer Z, Audikovszky M, Szocs A, et al. (2007) Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract 76: 351–357.
  7. 7. Ariyasu H, Takaya K, Hosoda H, Iwakura H, Ebihara K, et al. (2002) Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology 143: 3341–3350.
  8. 8. Kojima M, Kangawa K (2005) Ghrelin: structure and function. Physiol Rev 85: 495–522.
  9. 9. Smith RG, Jiang H, Sun Y (2005) Developments in ghrelin biology and potential clinical relevance. Trends Endocrinol Metab 16: 436–442.
  10. 10. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, et al. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37: 649–661.
  11. 11. Shimbara T, Mondal MS, Kawagoe T, Toshinai K, Koda S, et al. (2004) Central administration of ghrelin preferentially enhances fat ingestion. Neurosci Lett 369: 75–79.
  12. 12. Sun Y, Wang P, Zheng H, Smith RG (2004) Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A 101: 4679–4684.
  13. 13. Thielemans L, Peeters PJ, Jonckheere H, Luyten W, de Hoogt R, et al. (2007) The hepatocarcinoma cell line HepG2 does not express a GHS-R1a-type ghrelin receptor. J Recept Signal Transduct Res 27: 309–322.
  14. 14. Cassoni P, Ghe C, Marrocco T, Tarabra E, Allia E, et al. (2004) Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 150: 173–184.
  15. 15. Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, et al. (2006) Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147: 2306–2314.
  16. 16. Gauna C, Delhanty PJ, Hofland LJ, Janssen JA, Broglio F, et al. (2005) Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 90: 1055–1060.
  17. 17. Delhanty PJ, Sun Y, Visser JA, van Kerkwijk A, Huisman M, et al. (1749) Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS One 5: e11749.
  18. 18. Szentirmai E, Kapas L, Sun Y, Smith RG, Krueger JM (2009) The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice. Proc Natl Acad Sci U S A 106: 14069–14074.
  19. 19. Nedergaard J, Cannon B (2010) The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell Metab 11: 268–272.
  20. 20. Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277–359.
  21. 21. Nicholls DG, Locke RM (1984) Thermogenic mechanisms in brown fat. Physiol Rev 64: 1–64.
  22. 22. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, et al. (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360: 1500–1508.
  23. 23. Cannon B, Nedergaard JThyroid hormones: igniting brown fat via the brain. Nat Med 16: 965–967.
  24. 24. Mattson MPPerspective: Does brown fat protect against diseases of aging? Ageing Res Rev 9: 69–76.
  25. 25. Wijers SL, Saris WH, van Marken Lichtenbelt WD (2009) Recent advances in adaptive thermogenesis: potential implications for the treatment of obesity. Obes Rev 10: 218–226.
  26. 26. St-Onge MP, Gallagher DBody composition changes with aging: the cause or the result of alterations in metabolic rate and macronutrient oxidation? Nutrition 26: 152–155.
  27. 27. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, et al. (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360: 1509–1517.
  28. 28. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, et al. (2009) Functional brown adipose tissue in healthy adults. N Engl J Med 360: 1518–1525.
  29. 29. Pfannenberg C, Werner MK, Ripkens S, Stef I, Deckert A, et al. Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans. Diabetes 59: 1789–1793.
  30. 30. Kerckhoffs DA, Blaak EE, Van Baak MA, Saris WH (1998) Effect of aging on beta-adrenergically mediated thermogenesis in men. Am J Physiol 274: E1075–1079.
  31. 31. Kleiber M (1947) Body size and metabolic rate. Physiol Rev 27: 511–541.
  32. 32. Even PC, Mokhtarian A, Pele A (1994) Practical aspects of indirect calorimetry in laboratory animals. Neurosci Biobehav Rev 18: 435–447.
  33. 33. Shetty P (2005) Energy requirements of adults. Public Health Nutr 8: 994–1009.
  34. 34. Lowell BB, Spiegelman BM (2000) Towards a molecular understanding of adaptive thermogenesis. Nature 404: 652–660.
  35. 35. Hosoda H, Kojima M, Kangawa K (2002) Ghrelin and the regulation of food intake and energy balance. Mol Interv 2: 494–503.
  36. 36. Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407: 908–913.
  37. 37. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, et al. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707–709.
  38. 38. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, et al. (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87: 240–244.
  39. 39. Sun Y, Butte NF, Garcia JM, Smith RG (2008) Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 149: 843–850.
  40. 40. Sun Y, Ahmed S, Smith RG (2003) Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23: 7973–7981.
  41. 41. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, et al. (2005) Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 115: 3564–3572.
  42. 42. Wortley KE, del Rincon JP, Murray JD, Garcia K, Iida K, et al. (2005) Absence of ghrelin protects against early-onset obesity. J Clin Invest 115: 3573–3578.
  43. 43. Morley JE (2001) Anorexia, sarcopenia, and aging. Nutrition 17: 660–663.
  44. 44. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, et al. (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147: 755–763.
  45. 45. St-Onge MP (2005) Relationship between body composition changes and changes in physical function and metabolic risk factors in aging. Curr Opin Clin Nutr Metab Care 8: 523–528.
  46. 46. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, et al. (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50: 2540–2547.
  47. 47. Wiskin AE, Davies JH, Wootton SA, Beattie RMEnergy expenditure, nutrition and growth. Arch Dis Child.
    • 48. Marzullo P, Verti B, Savia G, Walker GE, Guzzaloni G, et al. (2004) The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 89: 936–939.
    • 49. Riis AL, Hansen TK, Moller N, Weeke J, Jorgensen JO (2003) Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab 88: 853–857.
    • 50. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, et al. (2006) Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116: 1983–1993.
    • 51. Yasuda T, Masaki T, Kakuma T, Yoshimatsu H (2003) Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neurosci Lett 349: 75–78.
    • 52. St-Pierre DH, Karelis AD, Cianflone K, Conus F, Mignault D, et al. (2004) Relationship between ghrelin and energy expenditure in healthy young women. J Clin Endocrinol Metab 89: 5993–5997.
    • 53. Krems C, Luhrmann PM, Strassburg A, Hartmann B, Neuhauser-Berthold M (2005) Lower resting metabolic rate in the elderly may not be entirely due to changes in body composition. Eur J Clin Nutr 59: 255–262.
    • 54. Jastroch M, Withers KW, Taudien S, Frappell PB, Helwig M, et al. (2008) Marsupial uncoupling protein 1 sheds light on the evolution of mammalian nonshivering thermogenesis. Physiol Genomics 32: 161–169.
    • 55. Sun Y, Garcia JM, Smith RG (2007) Ghrelin and growth hormone secretagogue receptor expression in mice during aging. Endocrinology 148: 1323–1329.
    • 56. Valle A, Guevara R, Garcia-Palmer FJ, Roca P, Oliver J (2008) Caloric restriction retards the age-related decline in mitochondrial function of brown adipose tissue. Rejuvenation Res 11: 597–604.
    • 57. Roti E, Minelli R, Salvi M (2000) Thyroid hormone metabolism in obesity. Int J Obes Relat Metab Disord 24: Suppl 2S113–115.
    • 58. Wolthers T, Groftne T, Moller N, Christiansen JS, Orskov H, et al. (1996) Calorigenic effects of growth hormone: the role of thyroid hormones. J Clin Endocrinol Metab 81: 1416–1419.
    • 59. Lopez M, Varela L, Vazquez MJ, Rodriguez-Cuenca S, Gonzalez CR, et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med 16: 1001–1008.
    • 60. Wabitsch M, Hauner H, Heinze E, Teller WM (1995) The role of growth hormone/insulin-like growth factors in adipocyte differentiation. Metabolism 44: 45–49.
    • 61. Franco C, Bengtsson BA, Johannsson G (2006) The GH/IGF-1 Axis in Obesity: Physiological and Pathological Aspects. Metab Syndr Relat Disord 4: 51–56.
    • 62. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, et al. (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310: 996–999.
    • 63. Rodriguez A, Gomez-Ambrosi J, Catalan V, Gil MJ, Becerril S, et al. (2009) Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond) 33: 541–552.
    • 64. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, et al. (2004) Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145: 234–242.
    • 65. Lagaud GJ, Young A, Acena A, Morton MF, Barrett TD, et al. (2007) Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun 357: 264–269.
    • 66. Carlini VP, Schioth HB, Debarioglio SR (2007) Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun 352: 907–912.
    • 67. Bresciani E, Rapetti D, Dona F, Bulgarelli I, Tamiazzo L, et al. (2006) Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest 29: RC16–18.
    • 68. Tsubone T, Masaki T, Katsuragi I, Tanaka K, Kakuma T, et al. (2005) Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regul Pept 130: 97–103.
    • 69. Obici S, Wang J, Chowdury R, Feng Z, Siddhanta U, et al. (2002) Identification of a biochemical link between energy intake and energy expenditure. J Clin Invest 109: 1599–1605.
    • 70. Nuotio-Antar AM, Hachey DL, Hasty AH (2007) Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Am J Physiol Endocrinol Metab 293: E1517–1528.
    • 71. Bancroft JD, Stevens A (1996) Theory and Practice of Histological Techniques. New York: Churchill Livingstone.
      • 72. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG (2006) Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3: 379–386.
      • 73. Justo R, Oliver J, Gianotti M (2005) Brown adipose tissue mitochondrial subpopulations show different morphological and thermogenic characteristics. Mitochondrion 5: 45–53.